Correlation Between Savara and Dyne Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Savara and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Savara and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Savara Inc and Dyne Therapeutics, you can compare the effects of market volatilities on Savara and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Savara with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Savara and Dyne Therapeutics.

Diversification Opportunities for Savara and Dyne Therapeutics

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Savara and Dyne is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Savara Inc and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Savara is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Savara Inc are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Savara i.e., Savara and Dyne Therapeutics go up and down completely randomly.

Pair Corralation between Savara and Dyne Therapeutics

Given the investment horizon of 90 days Savara Inc is expected to under-perform the Dyne Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Savara Inc is 1.38 times less risky than Dyne Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Dyne Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  1,156  in Dyne Therapeutics on September 2, 2024 and sell it today you would earn a total of  1,905  from holding Dyne Therapeutics or generate 164.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Savara Inc  vs.  Dyne Therapeutics

 Performance 
       Timeline  
Savara Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Savara Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Dyne Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dyne Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Dyne Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Savara and Dyne Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Savara and Dyne Therapeutics

The main advantage of trading using opposite Savara and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Savara position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.
The idea behind Savara Inc and Dyne Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios